MedPath

The TRICURE EFS Study

Not Applicable
Recruiting
Conditions
Tricuspid Valve Regurgitation
Heart Valve Diseases
Cardiovascular Diseases
Tricuspid Valve Regurgitation
Heart Valve Diseases
Cardiovascular Diseases
Interventions
Device: Transcatheter Tricuspid Valve Replacement
Registration Number
NCT06506942
Lead Sponsor
TRiCares
Brief Summary

Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System

Detailed Description

The study is a multi-center, prospective single arm study designed to evaluate the safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Adult patients
  • Tricuspid regurgitation grade 3 (severe) on a scale of 0 (none) to 5 (torrential)
  • Institutional Heart Team evaluates patient as being at increased operative risk
Exclusion Criteria
  • Patient in need of emergent intervention
  • Patient who is hemodynamically unstable
  • Anatomical contraindications for implantation with study device
  • Patient who is currently participating in another clinical investigation where the primary endpoint was not reached yet

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Transcatheter Tricuspid Valve ReplacementTranscatheter Tricuspid Valve ReplacementTreatment with the TRiCares Topaz Tricuspid Transcatheter Valve Replacement System
Primary Outcome Measures
NameTimeMethod
Device Successimmediately post-intervention

Device success defined as a reduction in tricuspid regurgitation immediately post-intervention

Composite of MAE30 day post-intervention

Composite rate of major adverse events (MAEs) at 30 days, including mortality, myocardial infarction, stroke and major complications.

Composite of MAE30 day post-intervention

Composite rate of major adverse events (MAEs) at 30 days, including mortality, myocardial infarction, stroke and major complications.

Device Successimmediately post-intervention

Device success defined as a reduction in tricuspid regurgitation immediately post-intervention

Secondary Outcome Measures
NameTimeMethod
New York Heart Association (NYHA) Function Class30 days, 6 months, annual for five years post-intervention

Number of patients presenting with improvement in NYHA classification

Reduction in Tricuspid Regurgitation (TR) Grade30 days, 6 months, annual for five years post-intervention

Number of patients presenting with reduction in TR grade compared to baseline assessment

Six minute walk test30 days, 6 months, annual for five years post-intervention

Change in distance (m) compared to baseline assessment

Six minute walk test30 days, 6 months, annual for five years post-intervention

Change in distance (m) compared to baseline assessment

Reduction in Tricuspid Regurgitation (TR) Grade30 days, 6 months, annual for five years post-intervention

Number of patients presenting with reduction in TR grade compared to baseline assessment

New York Heart Association (NYHA) Function Class30 days, 6 months, annual for five years post-intervention

Number of patients presenting with improvement in NYHA classification

Trial Locations

Locations (12)

Piedmont Healthcare Inc.

🇺🇸

Atlanta, Georgia, United States

University of Michigan Hospital and Health Systems

🇺🇸

Ann Arbor, Michigan, United States

Columbia University Medical Center/ NewYork Presbyterian Hospital

🇺🇸

New York, New York, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Piedmont Healthcare Inc.

🇺🇸

Atlanta, Georgia, United States

Northwestern

🇺🇸

Chicago, Illinois, United States

University of Michigan Hospital and Health Systems

🇺🇸

Ann Arbor, Michigan, United States

Minneapolis Heart Institute Foundation

🇺🇸

Minneapolis, Minnesota, United States

Montefiore

🇺🇸

Bronx, New York, United States

Columbia University Medical Center/ NewYork Presbyterian Hospital

🇺🇸

New York, New York, United States

The Christ Hospital

🇺🇸

Cincinnati, Ohio, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath